Advances in Bone Tissue 3D Bioprinting | Biofabrication

Biofabrication in Bone Tissue Engineering

Advances in Extrusion-Based 3D Bioprinting and Hybrid Scaffold Strategies

Graduate Research Seminar | 2026

Presentation Outline

Critical-sized bone defects represent a significant clinical challenge in orthopedics.

Autografts (gold standard) suffer from donor site morbidity and limited availability.

Allografts face risks of immune rejection and disease transmission.

3D Bioprinting enables patient-specific geometries and heterogeneous structures.

Introduction

The Clinical Challenge of Critical-Size Defects

Proposed Solution

The Hybrid Scaffold Concept

Methodology

Melt Extrusion (PCL) vs. Bioprinting (Hydrogel)

Geometric Design "Contestants"

Engineering Analysis

Mechanical Strength vs. Permeability

CFD Simulation & Wall Shear Stress (WSS)

Biological Validation

Cell Viability & Gradient Mineralization

Critical Review & Conclusions

Extrusion Bioprinting Fundamentals

Extrusion-based printing dispenses continuous filaments of material through a micro-nozzle using pneumatic, piston, or screw-driven pressure. It is the most versatile modality for viscous polymers and cell-laden hydrogels.

Key Parameters

Rheology: Shear-thinning behavior required for nozzle transit.

Crosslinking: UV, enzymatic, or thermal gelation post-extrusion.

Biomaterial: Rigid Scaffolds (Synthetic)

To mimic the cortical bone, synthetic polymers like Polycaprolactone (PCL) and PLA are used for their high mechanical strength and slow degradation rates.

Mechanical Strength Comparison

Biomaterial: Bioinks & Hydrogels

Mimic the extracellular matrix (ECM) to support cell viability.

Common Materials: GelMA, Alginate, PEG, Collagen.

Challenge: Low mechanical integrity makes them unsuitable for load-bearing applications alone.

Hybrid Biofabrication Strategy

Combines the load-bearing capacity of synthetic frames with the biological activity of cell-laden hydrogels.

Rigid PCL Frame (Mechanical Support)

Soft Bioink (Cell Niche)

Landmark Study: Gradient Bioink Deposition

Hybrid Scaffold with PCL Cage & hBMSCs

A hybrid scaffold was fabricated via 3D printing of a PCL cage structure and a PEG-based bioink comprising a varying number of human bone marrow mesenchymal stem cells (hBMSCs).

Microcapillary extrusion used to deposit the gradient bioink inside the PCL cage to generate a mineralized gradient structure mimicking natural bone transition.

Biological Performance Data

The hybrid approach demonstrates superior osteogenic potential compared to standard PCL scaffolds. Presence of bioceramics (HA/TCP) further enhances mineralization markers like ALP activity.

The Vascularization Challenge

Cells deeper than 200 µm from a nutrient source typically undergo necrosis.

Solution: Co-printing endothelial cells (HUVECs) or using sacrificial bioinks (e.g., Pluronic F-127) to create perfusable microchannels.

Future Directions in Bone Biofabrication

4D Printing: Scaffolds that change shape or properties post-implantation.

In Situ Bioprinting: Handheld devices (e.g., Biopen) for direct printing into defects.

Smart Bioinks: Materials responsive to pH or enzymatic triggers for controlled drug release.